4.8 Article

A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Virology

TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein

Mai Kishimoto et al.

Summary: The study found that exogenous expression of TMPRSS11D and TMPRSS13 enhances the cellular uptake and replication of the coronavirus, playing an important role in the infection of SARS-CoV-2. Additionally, SARS-CoV-1 and SARS-CoV-2 utilize the same proteases in the viral entry process.

VIRUSES-BASEL (2021)

Article Multidisciplinary Sciences

Distinct mechanisms for TMPRSS2 expression explain organ-specific inhibition of SARS-CoV-2 infection by enzalutamide

Fei Li et al.

Summary: Enzalutamide effectively inhibited SARS-CoV-2 infection in human prostate cells, however, such antiviral efficacy was lacking in human lung cells and organoids.

NATURE COMMUNICATIONS (2021)

Article Medicine, General & Internal

Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity

Markus Hoffmann et al.

Summary: The study demonstrates that Camostat mesylate and its metabolite GBPA can block the spread of SARS-CoV-2 in human lung tissue, and the related protease inhibitor Nafamostat mesylate exhibits enhanced antiviral activity.

EBIOMEDICINE (2021)

Article Biochemistry & Molecular Biology

Global Protease Activity Profiling Identifies HER2-Driven Proteolysis in Breast Cancer

Eugenia C. Salcedo et al.

Summary: Differential expression of extracellular proteases and endogenous protease inhibitors has been associated with distinct molecular subtypes of breast cancer. Through global identification of extracellular proteolysis, subtype-specific differences in protease activity and proteolysis associated with HER2-mediated signaling were elucidated.

ACS CHEMICAL BIOLOGY (2021)

Article Biochemistry & Molecular Biology

A Clinical-Stage Cysteine Protease Inhibitor blocks SARS-CoV-2 Infection of Human and Monkey Cells

Drake M. Mellott et al.

Summary: K777, an irreversible inactivator of cysteine proteases, has shown reduction in the infectivity of SARS-CoV-2 in various host cells. By inhibiting the activity of host cathepsin L, this drug prevents the processing of viral spike protein, thereby reducing viral infectivity.

ACS CHEMICAL BIOLOGY (2021)

Article Microbiology

The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways

Manon Laporte et al.

Summary: The high transmissibility of SARS-CoV-2 is related to the virus's abundant replication in the upper airways, which differs from other highly pathogenic coronaviruses. The spike protein of SARS-CoV-2 exhibits intrinsic temperature preference, optimizing the virus for the human respiratory tract and enhancing its transmission. Additionally, certain proteases in the human airways play a key role in activating the spike protein for virus entry, further increasing SARS-CoV-2's ability to spread.

PLOS PATHOGENS (2021)

Article Microbiology

The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets

Thomas P. Peacock et al.

Summary: Efficient transmission of SARS-CoV-2 among infected ferrets is dependent on a functional furin cleavage site in the spike protein. The virus has a selective advantage in lung cells and primary human airway epithelial cells due to a polybasic insertion, but replication may be impaired in certain cell lines.

NATURE MICROBIOLOGY (2021)

Review Medicine, Research & Experimental

Potential therapeutic agents to COVID-19: An update review on antiviral therapy, immunotherapy, and cell therapy

Mona Sadat Mirtaleb et al.

Summary: Various treatment strategies have been explored for COVID-19, including vaccines, antiviral drugs, immunotherapy, etc. Each treatment method has its own advantages and disadvantages, which need to be carefully considered in the treatment of COVID-19.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Article Biochemistry & Molecular Biology

TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect host cells

Jana Koch et al.

Summary: SARS-CoV-2 infects cells through two mutually exclusive pathways depending on the presence of TMPRSS2 protease. In the presence of TMPRSS2, the virus swiftly enters through the plasma membrane in a pH-independent manner; while in the absence of TMPRSS2, the virus is endocytosed and enters the cytosol post-infection.

EMBO JOURNAL (2021)

Article Chemistry, Multidisciplinary

Molecular mechanism of inhibiting the SARS-CoV-2 cell entry facilitator TMPRSS2 with camostat and nafamostat

Tim Hempel et al.

Summary: The study elucidates the molecular mechanism of camostat and nafamostat inhibiting the entry of SARS-CoV-2 into human lung cells and provides a model of the drugs binding to TMPRSS2. Nafamostat is found to have a higher propensity to form a stable covalent enzyme-substrate intermediate compared to camostat, explaining its higher potency.

CHEMICAL SCIENCE (2021)

Letter Microbiology

Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19

Markus Hoffmann et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)

Review Pharmacology & Pharmacy

Candidate drugs against SARS-CoV-2 and COVID-19

Dwight L. McKee et al.

PHARMACOLOGICAL RESEARCH (2020)

Review Biochemical Research Methods

Targeting Proteases for Treating COVID-19

Binquan Luan et al.

JOURNAL OF PROTEOME RESEARCH (2020)

Review Biochemistry & Molecular Biology

COVID-19: Targeting Proteases in Viral Invasion and Host Immune Response

Sanchit Seth et al.

FRONTIERS IN MOLECULAR BIOSCIENCES (2020)

Review Biochemistry & Molecular Biology

Recent Progress in the Drug Development Targeting SARS-CoV-2 Main Protease as Treatment for COVID-19

Wen Cui et al.

FRONTIERS IN MOLECULAR BIOSCIENCES (2020)

Article Chemistry, Medicinal

An Enzymatic TMPRSS2 Assay for Assessment of Clinical Candidates and Discovery of Inhibitors as Potential Treatment of COVID-19

Jonathan H. Shrimp et al.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)

Review Chemistry, Medicinal

Recent progress on inhibitors of the type II transmembrane serine proteases, hepsin, matriptase and matriptase-2

Vishnu C. Damalanka et al.

FUTURE MEDICINAL CHEMISTRY (2019)

Review Oncology

Cell surface-anchored serine proteases in cancer progression and metastasis

Carly E. Martin et al.

CANCER AND METASTASIS REVIEWS (2019)

Article Chemistry, Medicinal

Discovery of Selective Matriptase and Hepsin Serine Protease Inhibitors: Useful Chemical Tools for Cancer Cell Biology

Vishnu C. Damalanka et al.

JOURNAL OF MEDICINAL CHEMISTRY (2019)

Article Biochemistry & Molecular Biology

Piperidine carbamate peptidomimetic inhibitors of the serine proteases HGFA, matriptase and hepsin

Vishnu C. Damalanka et al.

MEDCHEMCOMM (2019)

Review Biochemistry & Molecular Biology

The role of type II transmembrane serine protease-mediated signaling in cancer

Lauren M. Tanabe et al.

FEBS JOURNAL (2017)

Review Biochemistry & Molecular Biology

TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections

Li Wen Shen et al.

BIOCHIMIE (2017)

Article Multidisciplinary Sciences

Proteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropism

Jung-Eun Park et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Article Virology

TMPRSS2 Is an Activating Protease for Respiratory Parainfluenza Viruses

Masako Abe et al.

JOURNAL OF VIROLOGY (2013)

Article Multidisciplinary Sciences

Effect of Signal Peptide on Stability and Folding of Escherichia coli Thioredoxin

Pranveer Singh et al.

PLOS ONE (2013)

Article Microbiology

Tmprss2 Is Essential for Influenza H1N1 Virus Pathogenesis in Mice

Bastian Hatesuer et al.

PLOS PATHOGENS (2013)

Article Biochemical Research Methods

Global identification of peptidase specificity by multiplex substrate profiling

Anthony J. O'Donoghue et al.

NATURE METHODS (2012)

Review Biochemistry & Molecular Biology

Type II Transmembrane Serine Proteases

Thomas H. Bugge et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2009)

Article Biochemical Research Methods

Enzymatic assembly of DNA molecules up to several hundred kilobases

Daniel G. Gibson et al.

NATURE METHODS (2009)

Review Biochemistry & Molecular Biology

Type II transmembrane serine proteases in cancer and viral infections

So-Young Choi et al.

TRENDS IN MOLECULAR MEDICINE (2009)

Article Multidisciplinary Sciences

Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection

K Chandran et al.

SCIENCE (2005)